Gastrointestinal & Liver Disease
When you make a donation to the MMRF, you leave a legacy that will impact the health and well-being of people for years to come. Donations of any amount make a difference, and by giving to the MMRF you support the advance of medicine in a wide variety of fields, from pediatrics to geriatrics.
Make a difference, donate today!
Heart Disease
MMRF researchers are at the forefront of testing and administering some of the most effective treatments in the country for coronary artery disease and heart failure.
Hennepin County Medical Center (HCMC) was the first hospital in the upper Midwest to use Tissue Plasminogen Activator (TPA), which breaks up blood clots, and the first in the world to use TNK TPA which is an altered, more potent form of TPA with fewer side effects.
MMRF researchers were leaders of the Stroke Prevention in Atrial Fibrillation (SPAF) study, which defined the role of blood thinners, and aspirin in preventing strokes in patients with atrial fibrillation.
MMRF also has a 17-year history of leading-edge research into the physiology and therapy for heart failure, testing many new medications for acute and chronic heart failure.
Whether patients are experiencing their first cardiac episode or have been disabled for years, research conducted within the Hennepin Heart Center makes it the place to go for the most state-of-the-art treatment available.
Steven Goldsmith, M.D
Director of Cardiology
Richard W. Asinger, M.D.
Associate Director of Cardiology
Bradley Bart, M.D.
Director of Nuclear Cardiac Imaging
Charles Herzog, M.D.
Director of Echocardiography
Richard D. Taylor, M.D.
Director of Electrophysiology
Valerie Ulstad, MD
Director of Cardiovascular Education
Marco Guerrero, MD
©2008 Minneapolis Medical Research Foundation
MMRF Webmaster
Last Modified:
June 6, 2008
